標(biāo)題: Titlebook: Brachytherapy; Techniques and Evide Yasuo Yoshioka,Jun Itami,Takashi Nakano Book 2019 Springer Nature Singapore Pte Ltd. 2019 Uterine cervi [打印本頁] 作者: FROM 時(shí)間: 2025-3-21 19:20
書目名稱Brachytherapy影響因子(影響力)
書目名稱Brachytherapy影響因子(影響力)學(xué)科排名
書目名稱Brachytherapy網(wǎng)絡(luò)公開度
書目名稱Brachytherapy網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Brachytherapy被引頻次
書目名稱Brachytherapy被引頻次學(xué)科排名
書目名稱Brachytherapy年度引用
書目名稱Brachytherapy年度引用學(xué)科排名
書目名稱Brachytherapy讀者反饋
書目名稱Brachytherapy讀者反饋學(xué)科排名
作者: nephritis 時(shí)間: 2025-3-21 23:52
Nikos Darzentas,Kostas Stamatopoulos Fractionated regimen of HDR intracavitary brachytherapy of cervical cancer was established in the 1970s based upon an extensive analysis of clinical findings of the patients undergoing HDR and LDR brachytherapies. It was the first report deriving HDR and LDR equivalent doses not from theoretical co作者: magenta 時(shí)間: 2025-3-22 03:45 作者: upstart 時(shí)間: 2025-3-22 06:52
CNS Lymphoma in the Immunocompromised Hostt 100?years. ICBT has been performed based on the two-dimensional (2D) planning with the use of orthogonal X-ray films for a long time. Doses are prescribed at point A according to the classical or modified Manchester systems. Recently, a dramatic shift has occurred from 2D to three-dimensional (3D)作者: Condyle 時(shí)間: 2025-3-22 11:48
https://doi.org/10.1007/978-94-009-8279-6g (MRI) or computed tomography (CT) has been used for calculating the dose to the tumor and organs at risk (OARs). Guidelines published by the GEC-ESTRO (Groupe Européen de Curiethérapie—European SocieTy for Radiotherapy & Oncology) and the American Brachytherapy Society (ABS) defined the delineatio作者: 使饑餓 時(shí)間: 2025-3-22 16:56 作者: 蜈蚣 時(shí)間: 2025-3-22 17:51
Cell-mediated Immunity in Lymphomas,has made great contributions in the establishment of optimal therapy for this disease over the course of five decades. Japanese institutions have recently conducted several clinical studies of three-dimensional image-guided brachytherapy. Based on these experiences, several Japanese institutions hav作者: Gesture 時(shí)間: 2025-3-23 00:28
Pathogenesis of Cutaneous T Cell Lymphomale in the treatment paradigm of low-, intermediate-, and high-risk prostate cancers. Brachytherapy is typically an outpatient procedure where tiny radioactive “seeds” are implanted in the prostate to eradicate the cancer right where it has grown. Brachytherapy has a long and proven track record with作者: COW 時(shí)間: 2025-3-23 02:13
Pathogenesis of Cutaneous T Cell Lymphomae radiation safety parameters including the qualifications of the institutions and doctors to perform this treatment. To evaluate the safety and efficacy of PPB for localized prostate cancer, the nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS) was作者: 邪惡的你 時(shí)間: 2025-3-23 09:21 作者: Synapse 時(shí)間: 2025-3-23 12:41 作者: 無可非議 時(shí)間: 2025-3-23 15:21 作者: 尊敬 時(shí)間: 2025-3-23 21:41
Intravascular Lymphoma of the CNSIntegration of medical imaging into the practice of brachytherapy has a potential to improve the precision in estimating clinical outcomes. Here, we will discuss state-of-the-art computational techniques to incorporate spatial consideration into the prediction of radiation toxicities in the various contexts of brachytherapy.作者: 散布 時(shí)間: 2025-3-24 00:04
Modern Computational Technologies for Establishing Precision Brachytherapy: From Non-rigid Image RegIntegration of medical imaging into the practice of brachytherapy has a potential to improve the precision in estimating clinical outcomes. Here, we will discuss state-of-the-art computational techniques to incorporate spatial consideration into the prediction of radiation toxicities in the various contexts of brachytherapy.作者: Coterminous 時(shí)間: 2025-3-24 04:50 作者: 會(huì)議 時(shí)間: 2025-3-24 08:26 作者: preeclampsia 時(shí)間: 2025-3-24 14:07 作者: 是突襲 時(shí)間: 2025-3-24 18:07 作者: Scintigraphy 時(shí)間: 2025-3-24 22:22
CNS Lymphoma in the Immunocompromised Hostreviewed the history and clinical results of the 2D- and 3D-ICBT procedures. We also mentioned the issues and future challenges of image-guided brachytherapy (3D-IGBT) in the treatment of uterine cervical cancer.作者: Ambiguous 時(shí)間: 2025-3-25 01:38
Lymphoproliferative Diseases of the Skin0?years. Since its dawning with four- to nine-fraction regimens, HDR monotherapy has been moving on to more and more hypofractionated regimens. The latest two- or single-fraction HDR monotherapy is vigorously discussed.作者: deforestation 時(shí)間: 2025-3-25 05:43
https://doi.org/10.1007/978-94-009-5016-0he operating theatre..We are going to discuss about dose equivalence to normofractionation using alpha-beta model. And last, we are going to describe our technique in detail and our institution’s result.作者: 發(fā)炎 時(shí)間: 2025-3-25 11:04
Intracavitary Brachytherapy from 2D to 3Dreviewed the history and clinical results of the 2D- and 3D-ICBT procedures. We also mentioned the issues and future challenges of image-guided brachytherapy (3D-IGBT) in the treatment of uterine cervical cancer.作者: 都相信我的話 時(shí)間: 2025-3-25 14:59
High-Dose-Rate Brachytherapy as Monotherapy for Prostate Cancer0?years. Since its dawning with four- to nine-fraction regimens, HDR monotherapy has been moving on to more and more hypofractionated regimens. The latest two- or single-fraction HDR monotherapy is vigorously discussed.作者: 騷擾 時(shí)間: 2025-3-25 19:11
Single-Fraction HDR Boosthe operating theatre..We are going to discuss about dose equivalence to normofractionation using alpha-beta model. And last, we are going to describe our technique in detail and our institution’s result.作者: 宏偉 時(shí)間: 2025-3-25 21:35
Japan.Sheds light on new approaches to brachytherapyThis book provides a comprehensive and up-to-date overview of major technical advances and research findings in the field of brachytherapy. Especially research conducted on brachytherapy in Japan has made tremendous strides, offering readers valuab作者: Guileless 時(shí)間: 2025-3-26 02:45
Nikos Darzentas,Kostas Stamatopoulosfindings of the patients undergoing HDR and LDR brachytherapies. It was the first report deriving HDR and LDR equivalent doses not from theoretical consideration of power law theories prevalent at that time. Various milestone reports of HDR brachytherapy have been published from Japanese groups.作者: 損壞 時(shí)間: 2025-3-26 07:48
Cell-mediated Immunity in Lymphomas,ntly conducted several clinical studies of three-dimensional image-guided brachytherapy. Based on these experiences, several Japanese institutions have conducted international cooperative activities on radiotherapy for cervical cancer with other Asian countries for over 20?years.作者: 小故事 時(shí)間: 2025-3-26 11:48 作者: anaphylaxis 時(shí)間: 2025-3-26 14:07
Asian Cooperation and Global Trends in Brachytherapy for Cervical Cancerntly conducted several clinical studies of three-dimensional image-guided brachytherapy. Based on these experiences, several Japanese institutions have conducted international cooperative activities on radiotherapy for cervical cancer with other Asian countries for over 20?years.作者: 典型 時(shí)間: 2025-3-26 18:44
Book 2019 research conducted on brachytherapy in Japan has made tremendous strides, offering readers valuable insights into new treatment outcomes, evidence and techniques. In the respective chapters, each author elucidates cutting-edge findings, addressing both the basic and clinical aspects including the a作者: 沉思的魚 時(shí)間: 2025-3-27 00:14 作者: Adornment 時(shí)間: 2025-3-27 03:59 作者: 參考書目 時(shí)間: 2025-3-27 07:53 作者: 俗艷 時(shí)間: 2025-3-27 13:30
Brachytherapy APBI: Japanese Experience and Asian Trendrving surgery, cylindrical resection, is especially different in that it leaves no cavity in the breast. The CTV after Asian surgery, therefore, needs special consideration. Consensus on surgical approach and CTV for small breast is still open for discussion. In this chapter we focus on the surgical techniques and evidences from Asian countries.作者: 雪白 時(shí)間: 2025-3-27 16:50 作者: 我還要背著他 時(shí)間: 2025-3-27 21:50 作者: 支架 時(shí)間: 2025-3-28 01:08
Japanese Brachytherapy in the?World Fractionated regimen of HDR intracavitary brachytherapy of cervical cancer was established in the 1970s based upon an extensive analysis of clinical findings of the patients undergoing HDR and LDR brachytherapies. It was the first report deriving HDR and LDR equivalent doses not from theoretical co作者: 陳腐思想 時(shí)間: 2025-3-28 04:09
Moving on from?LDR to HDRigh-dose-rate (HDR) intracavitary brachytherapy was developed to overcome some drawbacks of LDR brachytherapy (e.g., exposure of the medical staff and long treatment time). After biological effects including fractionation effects of HDR brachytherapy were determined by basic and clinical studies, HD作者: 無意 時(shí)間: 2025-3-28 10:07
Intracavitary Brachytherapy from 2D to 3Dt 100?years. ICBT has been performed based on the two-dimensional (2D) planning with the use of orthogonal X-ray films for a long time. Doses are prescribed at point A according to the classical or modified Manchester systems. Recently, a dramatic shift has occurred from 2D to three-dimensional (3D)作者: Essential 時(shí)間: 2025-3-28 14:03 作者: 可觸知 時(shí)間: 2025-3-28 15:05
Interstitial Brachytherapy: Radical and Salvageround clinical target volume (CTV); ISBT may achieve a better CTV coverage than an intracavitary brachytherapy and intracavitary/interstitial brachytherapy (ICISBT)..ISBT for gynecological tumor started since the 1910s, and its technique was a two-dimensional freehand implantation technique using lo作者: 適宜 時(shí)間: 2025-3-28 20:03
Asian Cooperation and Global Trends in Brachytherapy for Cervical Cancerhas made great contributions in the establishment of optimal therapy for this disease over the course of five decades. Japanese institutions have recently conducted several clinical studies of three-dimensional image-guided brachytherapy. Based on these experiences, several Japanese institutions hav作者: Nebulizer 時(shí)間: 2025-3-28 23:48 作者: 整理 時(shí)間: 2025-3-29 05:39
A Review of Permanent Prostate Brachytherapy as Practiced in Japane radiation safety parameters including the qualifications of the institutions and doctors to perform this treatment. To evaluate the safety and efficacy of PPB for localized prostate cancer, the nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS) was作者: 涂掉 時(shí)間: 2025-3-29 08:32 作者: objection 時(shí)間: 2025-3-29 13:51 作者: 悲痛 時(shí)間: 2025-3-29 18:47
Brachytherapy APBI: Japanese Experience and Asian Trendca, where simple lumpectomy can be indicated for most patients. In Asia, IMB-APBI is gradually gaining popularity but still in a much slower pace. The breast size in Asia is commonly smaller, and the surgical approach is accordingly different from Western countries. Among them, Japanese breast-conse作者: Abnormal 時(shí)間: 2025-3-29 20:58
History of Brachytherapy in Japanociety for Radiation Oncology (JASTRO). Interest in not only academic activities but also education and quality assurance was raised. The academic activity is shown through the increased number of published articles written in English by Japanese authors.作者: GONG 時(shí)間: 2025-3-30 00:44
Hybrid Brachytherapyd reproducible insertion is achieved by using tandem and ring/ovoid applicators, as the short distance between the ring/ovoid and target allows for greater control of needle placements. In recent studies, HBT delivered higher doses to bulky tumors, poor response tumors, and severe parametrial extens作者: miniature 時(shí)間: 2025-3-30 06:38 作者: Externalize 時(shí)間: 2025-3-30 10:21
Prostate Brachytherapy: Clinical Efficacy and Future Trendstions, to include a shift to active surveillance. With prostate cancer diagnosis on the rise, and prospective and randomized trials showing brachytherapy’s superior efficacy over other modalities such as radical prostatectomy and EBRT, it is important to put corrective actions in place to ensure tha作者: OVER 時(shí)間: 2025-3-30 15:54
